Health Sciences

The Botswana-UPenn Partnership can trace its roots back 11 years to a collaboration of medical professionals recruited to help stem the tide of AIDS infections in that southern African country.

PHILADELPHIA — Researchers from the Perelman School of Medicine at the University of Pennsylvania have been awarded a $3.7 million grant from the National Institutes of Health (NIH) to establish a new translational interdisciplinary research center to explore the role of sex and gender in behavioral health.

PHILADELPHIA –- The Field Center for Children’s Policy, Practice & Research at the University of Pennsylvania will host its second annual Field of Dreams Luncheon Friday, Oct. 12, at the College of Physicians, 19 S. 22nd St., Philadelphia.

WHAT: Penn Medicine and Penn Presbyterian Medical Center, in partnership with The University City Science Center and Wexford Science & Technology, are set to break ground on a new 11-story tower at 3737 Market Street on The Science Center’s Campus in West Philadelphia. Penn Presbyterian Medical Center will be the anchor tenant.

PHILADELPHIA – A team of researchers led by Edna Foa PhD, professor of Clinical Psychology in Psychiatry and director of the Center for the Treatment and Study of Anxiety (CTSA) at the Perelman School of Medi

Whenever Miguel Padilla-Hernández, a fourth-year student in the University of Pennsylvania School of Dental Medicine, visits his family back in California, conversations are peppered with questions such as, “’Oh, this tooth hurts, why does this tooth hurt?” or “Why is this tooth changing colors?”

PHILADELPHIA — It’s not every day that a new academic discipline is born. But that’s exactly what happened in 2010, when the Project on Bioethics, Sexuality and Gender Identity — or “Queer Bioethics,” for short — came to life at the University of Pennsylvania.

PHILADELPHIA — We often hear that “knowledge is power.” But, that isn’t always the case, especially when the knowledge pertains to the health of an unborn child, with murky implications, at best.

PHILADELPHIA — Dogs with hemangiosarcoma that were treated with a compound derived from the Coriolus versicolor mushroom had the longest survival times ever reported for dogs with the disease. These promising findings offer hope that the compound may one day offer cancer patients — human and canine alike — a viable alternative or complementary treatment to traditional chemotherapies.